NLRP3 and colitis: Although the detailed mechanisms through which NLRP3 pathway modulation mitigates DSS-induced colitis are still being delineated, it is clear that manipulating this pathway and maintaining intestinal barrier integrity are essential strategies in the therapeutic management of inflammatory bowel diseases.